Inhibition of AKT Pathway Augments Combination Therapy

Otolaryngology - Head and Neck Surgery - United States
doi 10.1016/j.otohns.2010.06.074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Inhibition of the GAS6/AXL Pathway Augments the Efficacy of Chemotherapies

Journal of Clinical Investigation
Medicine
2016English

Cucurbitacin Augments Insulin Sensitivity and Glucose Uptake Through Translocation and Activation of Glut4 in Pi3k/Akt Signaling Pathway

World Journal of Pharmaceutical Research
2017English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Inhibition of Esophageal Cancer Growth Through the Suppression of PI3K/AKT/mTOR Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

PI3K-PKB/Akt Pathway

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2012English

Inhibition of the AKT Pathway in Cholangiocarcinoma by MK2206 Reduces Cellular Viability via Induction of Apoptosis

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

Combination Treatment of Ligustrazine Piperazine Derivate DLJ14 and Adriamycin Inhibits Progression of Resistant Breast Cancer Through Inhibition of the EGFR/PI3K/Akt Survival Pathway and Induction of Apoptosis

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy